Search

Your search keyword '"Joly, Jean-Paul"' showing total 45 results
Start Over Author "Joly, Jean-Paul"
45 results on '"Joly, Jean-Paul"'

1. Data from BAD, a Proapoptotic Member of the BCL2 Family, Is a Potential Therapeutic Target in Hepatocellular Carcinoma

Author

Galmiche, Antoine, primary, Ezzoukhry, Zakaria, primary, François, Catherine, primary, Louandre, Christophe, primary, Sabbagh, Charles, primary, Nguyen-Khac, Eric, primary, Descamps, Véronique, primary, Trouillet, Nathalie, primary, Godin, Corinne, primary, Regimbeau, Jean-Marc, primary, Joly, Jean-Paul, primary, Barbare, Jean-Claude, primary, Duverlie, Gilles, primary, Mazière, Jean-Claude, primary, and Chatelain, Denis, primary

Published
2023
Full Text
View/download PDF

2. Supplementary Data from BAD, a Proapoptotic Member of the BCL2 Family, Is a Potential Therapeutic Target in Hepatocellular Carcinoma

Author

Galmiche, Antoine, primary, Ezzoukhry, Zakaria, primary, François, Catherine, primary, Louandre, Christophe, primary, Sabbagh, Charles, primary, Nguyen-Khac, Eric, primary, Descamps, Véronique, primary, Trouillet, Nathalie, primary, Godin, Corinne, primary, Regimbeau, Jean-Marc, primary, Joly, Jean-Paul, primary, Barbare, Jean-Claude, primary, Duverlie, Gilles, primary, Mazière, Jean-Claude, primary, and Chatelain, Denis, primary

Published
2023
Full Text
View/download PDF

6. Individual patient data meta-analysis of adjuvant gemcitabine-based chemotherapy for biliary tract cancer: combined analysis of the BCAT and PRODIGE-12 studies

Author

Edeline, Julien, primary, Hirano, Satoshi, additional, Bertaut, Aurélie, additional, Konishi, Masaru, additional, Benabdelghani, Meher, additional, Uesaka, Katsuhiko, additional, Watelet, Jérôme, additional, Ohtsuka, Masayuki, additional, Hammel, Pascal, additional, Kaneoka, Yuji, additional, Joly, Jean-Paul, additional, Yamamoto, Masakazu, additional, Monard, Laure, additional, Ambo, Yoshiyasu, additional, Louvet, Christophe, additional, Ando, Masahiko, additional, Malka, David, additional, Nagino, Masato, additional, Phelip, Jean-Marc, additional, and Ebata, Tomoki, additional

Published
2022
Full Text
View/download PDF

12. Échographie et maladies inflammatoires chroniques de l'intestin.

Author

Yzet, Clara, Aygalenq, Philippe, Joly, Jean-Paul, Brazier, Franck, Yzet, Thierry, and Fumery, Mathurin

Abstract

Résumé: L'endoscopie est l'examen de référence pour le diagnostic et la surveillance des maladies inflammatoires chroniques intestinales (MICI). À l'heure des stratégies de « tight-control » et de « treat-to-target », le développement de biomarqueurs ou d'examen non invasif, bien toléré, répétable et peu coûteux est indispensable. Comparativement, à l'endoscopie ou à l'imagerie en coupe, l'échographie intestinale s'est avérée performante dans l'évaluation et la surveillance de l'activité de la maladie de Crohn et de la rectocolite hémorragique. Elle peut être réalisée « au chevet du malade » et permettre ainsi une prise de décision clinique en temps réel. L'objectif de cette revue est d'effectuer une mise au point sur la place actuelle et future de l'échographie dans les MICI. The gold standard for the diagnosis and monitoring of inflammatory bowel disease (IBD) is the colonoscopy. In the era of "tight control" and "treat to target" strategies, the development of non-invasive, well-tolerated, repeatable and inexpensive biomarkers are needed. Compared to colonoscopy and Magnetic resonance imaging, bowel ultrasound (US) has shown to have the same level of accuracy in assessing and monitoring disease activity and severity of both Crohn's disease and ulcerative colitis. It can be performed at the point-of-care and therefore allow for real-time clinical decision-making. The aim of this review is to discuss the interest of intestinal ultrasound in the management of patients with IBD. The objective of this review is to provide an update on the current and future place of ultrasound in IBD. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

13. Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study

Author

Edeline, Julien, primary, Benabdelghani, Meher, additional, Bertaut, Aurélie, additional, Watelet, Jérôme, additional, Hammel, Pascal, additional, Joly, Jean-Paul, additional, Boudjema, Karim, additional, Fartoux, Laetitia, additional, Bouhier-Leporrier, Karine, additional, Jouve, Jean-Louis, additional, Faroux, Roger, additional, Guerin-Meyer, Véronique, additional, Kurtz, Jean-Emmanuel, additional, Assénat, Eric, additional, Seitz, Jean-François, additional, Baumgaertner, Isabelle, additional, Tougeron, David, additional, de la Fouchardière, Christelle, additional, Lombard-Bohas, Catherine, additional, Boucher, Eveline, additional, Stanbury, Trevor, additional, Louvet, Christophe, additional, Malka, David, additional, and Phelip, Jean-Marc, additional

Published
2019
Full Text
View/download PDF

20. Gemox versus surveillance following surgery of localized biliary tract cancer: Results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial.

Author

Edeline, Julien, primary, Bonnetain, Franck, additional, Phelip, Jean Marc, additional, Watelet, Jérôme, additional, Hammel, Pascal, additional, Joly, Jean-Paul, additional, Ben Abdelghani, Meher, additional, Rosmorduc, Olivier, additional, Bouhier-Leporrier, Karine, additional, Jouve, Jean-Louis, additional, Faroux, Roger, additional, Guerin Meyer, Véronique, additional, Assenat, Eric, additional, Seitz, Jean Francois, additional, Malka, David, additional, Louvet, Christophe, additional, Bertaut, Aurelie, additional, Juzyna, Beata, additional, Stanbury, Trevor, additional, and Boucher, Eveline, additional

Published
2017
Full Text
View/download PDF

25. A Lymph Node Ratio of 10% Is Predictive of Survival in Stage III Colon Cancer: A French Regional Study

Author

Sabbagh, Charles, primary, Mauvais, François, additional, Cosse, Cyril, additional, Rebibo, Lionel, additional, Joly, Jean-Paul, additional, Dromer, Didier, additional, Aubert, Christine, additional, Carton, Sophie, additional, Dron, Bernard, additional, Dadamessi, Innocenti, additional, Maes, Bernard, additional, Perrier, Guillaume, additional, Manaouil, David, additional, Fontaine, Jean-François, additional, Gozy, Michel, additional, Panis, Xavier, additional, Foncelle, Pierre Henri, additional, de Fresnoy, Hugues, additional, Leroux, Fabien, additional, Vaneslander, Pierre, additional, Ghighi, Caroline, additional, and Regimbeau, Jean-Marc, additional

Published
2014
Full Text
View/download PDF

27. BAD, a Proapoptotic Member of the BCL2 Family, Is a Potential Therapeutic Target in Hepatocellular Carcinoma

Author

Galmiche, Antoine, primary, Ezzoukhry, Zakaria, additional, François, Catherine, additional, Louandre, Christophe, additional, Sabbagh, Charles, additional, Nguyen-Khac, Eric, additional, Descamps, Véronique, additional, Trouillet, Nathalie, additional, Godin, Corinne, additional, Regimbeau, Jean-Marc, additional, Joly, Jean-Paul, additional, Barbare, Jean-Claude, additional, Duverlie, Gilles, additional, Mazière, Jean-Claude, additional, and Chatelain, Denis, additional

Published
2010
Full Text
View/download PDF

28. Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multicenter French study

Author

Nguyen-Khac, Eric, primary, Ollivier, Isabelle, additional, Aparicio, Thomas, additional, Moullart, Véronique, additional, Hugentobler, Alexis, additional, Lebtahi, Rachida, additional, Lobry, Céline, additional, Susini, Christiane, additional, Duhamel, Christian, additional, Hommel, Séverine, additional, Cadranel, Jean François, additional, Joly, Jean-paul, additional, Barbare, Jean Claude, additional, Tramier, Blaise, additional, and Dupas, Jean Louis, additional

Published
2009
Full Text
View/download PDF

29. Assessment of Baseline Clinical Predictive Factors of Response to Cetuximab-Irinotecan in Patients with Irinotecan-Refractory Metastatic Colorectal Cancer

Author

Hebbar, Mohamed, primary, Di Fioré, Frédéric, additional, Conroy, Thierry, additional, Giraud, Claire, additional, Gasnault, Laurent, additional, Fournier, Charles, additional, Péreira, Renata, additional, Bouché, Olivier, additional, Fournier, Peggy, additional, Deligny, Nathalie, additional, Joly, Jean-Paul, additional, Maes, Patricia, additional, Rad, Emilia, additional, Michel, Pierre, additional, and Adenis, Antoine, additional

Published
2007
Full Text
View/download PDF

36. Cirrhosis

Author

Duchmann, Jean-Christophe, primary, Joly, Jean-Paul, additional, Decrombecque, Catherine, additional, Delcenserie, Richard, additional, L??vy, St??phane, additional, Capron, Dominique, additional, and Capron, Jean-Pierre, additional

Published
1997
Full Text
View/download PDF

41. Multidisciplinary management of Mirizzi syndrome with cholecystobiliary fistula: the value of minimally invasive endoscopic surgery.

Author

Le Roux F, Sabbagh C, Robert B, Yzet T, Dugue L, Joly JP, and Regimbeau JM

Subjects
Aged, Biliary Fistula etiology, Common Bile Duct Diseases etiology, Female, Gallstones complications, Humans, Length of Stay, Male, Middle Aged, Mirizzi Syndrome etiology, Retrospective Studies, Young Adult, Biliary Fistula surgery, Cholangiopancreatography, Endoscopic Retrograde, Common Bile Duct Diseases surgery, Drainage, Gallstones surgery, Mirizzi Syndrome surgery
Abstract

Mirizzi syndrome, a rare complication of gallstones, is defined by obstruction of the main bile duct. This obstruction may worsen and thus result in cholecystobiliary fistula. Surgical management of Mirizzi syndrome is complicated by the presence of inflamed tissue around the hepatic pedicle, making it impossible to distinguish between the main bile duct and the gallbladder. The surgeon's first task is to perform subtotal cholecystotomy (from the fundus of the gallbladder to the neck) without trying to locate the cystic duct. In a second step, the gallstones are extracted and the main bile duct is then repaired. In most cases, a T-tube is used to drain the main bile duct, and abdominal drainage is left in place (in case a bile fistula forms). This study concluded that preoperative drainage of the main bile duct in the treatment of Mirizzi syndrome types II and III is feasible and might help to decrease the postoperative complication rate.

Published
2015
Full Text
View/download PDF

42. Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multi-center French study.

Author

Nguyen-Khac E, Ollivier I, Aparicio T, Moullart V, Hugentobler A, Lebtahi R, Lobry C, Susini C, Duhamel C, Hommel S, Cadranel JF, Joly JP, Barbare JC, Tramier B, and Dupas JL

Subjects
Adult, Aged, Aged, 80 and over, Carcinoma, Hepatocellular metabolism, Carcinoma, Hepatocellular pathology, France, Humans, Immunohistochemistry, Indium Radioisotopes pharmacokinetics, Liver Neoplasms metabolism, Liver Neoplasms pathology, Male, Middle Aged, Multivariate Analysis, Neoplasm Staging, Radionuclide Imaging methods, Radiopharmaceuticals pharmacokinetics, Receptors, Somatostatin metabolism, Somatostatin analogs & derivatives, Somatostatin pharmacokinetics, Treatment Outcome, Carcinoma, Hepatocellular diagnostic imaging, Liver Neoplasms diagnostic imaging, Receptors, Somatostatin analysis
Abstract

Background: Somatostatin receptor scintigraphy (SRS) has been reported for receptor (SSTR) screening in advanced hepatocarcinoma (aHC) prior to somatostatin analogue treatment., Aims: To evaluate SSTR screening with SRS in aHC patients., Results: Seventy aHC patients (63 men) aged 65 +/- 11 y were included, with alcohol, viral or other causes cirrhosis in 35 (50%), 23 (33%), 12 (17%) cases respectively. CLIP score was 2.7 +/- 1.7, with more than three nodules in 37 (53%) cases. Largest nodule measured 7.6 +/- 4.5 cm. Median alpha-fetoprotein was 574 UI/mL. SRS was positive in 25/70 (35.7%) livers and 7/17 (41.2%) metastatic sites. Positive SRS patients differed from others for tumor size (9.2 +/- 4 vs. 6.7 +/- 4.6 cm, p = 0.03), prothrombin time (PT) (75.2 +/- 15.2 vs. 61.9 +/- 19%, p = 0.005), albumin (34.1 +/- 5.9 vs. 30.5 +/- 7.2 g/L, p = 0.04) and Child-Pugh (6.7 +/- 1.8 vs. 7.7 +/- 2.3, p = 0.04). After multivariate analysis, only PT was associated with positive SRS (p = 0.028). Immunohistochemistry was positive for SSTR2s in 6/7 tumors (SRS uptake in 5/6 cases)., Methods: SRS was performed prior treatment, with images at 4, 24 and 48 h. For seven tumors, SSTR2 subtype was detected immunohistochemically., Conclusions: In advanced hepatocarcinoma, we report SRS uptake in 35.7% of livers and 41.2% of metastatic sites. SRS value in screening patients for somatostatin analogue treatment remains to be assessed.

Published
2009
Full Text
View/download PDF

44. Reactive nodular fibrous pseudotumor of the gastrointestinal tract and mesentery.

Author

Chatelain D, Manaouil D, Levy P, Joly JP, Sevestre H, and Regimbeau JM

Subjects
Adult, Biomarkers analysis, Gastrointestinal Diseases metabolism, Gastrointestinal Diseases surgery, Humans, Male, Mesentery metabolism, Peritoneal Diseases metabolism, Peritoneal Diseases surgery, Treatment Outcome, Fibrosis pathology, Gastrointestinal Diseases pathology, Mesentery pathology, Peritoneal Diseases pathology
Published
2004
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results